Table 2. Costs due to TB care incurred by patients at different stages enrolled in TB patient cost survey, China, 2020 (N=3,286).
| Costs (USD) | Before-TB designated hospital | After-TB designated hospital | TB care overall | |||||
| Median | (IQR) | Median | (IQR) | Median | (IQR) | |||
| Abbreviation: TB=tuberculosis; USD=US dollar; IQR=interquartile range. * Direct medical and direct non-medical costs combined. † Out of pocket (OOP) medical expenditures associated with TB diagnosis, treatment and treatment seeking. § OOP costs for transportation, accommodation and food of the patients and family members. ¶ Productivity and economic costs of a patient and his/her household incurred as a result of TB care visits and hospitalization during the TB episode. ** Direct and indirect costs combined. | ||||||||
| Direct costs* | 210.2 | (34.0–747.4) | 494.0 | (206.5–1154.3) | 1041.3 | (534.5–1965.0) | ||
| Direct medical costs† | 148.8 | (22.2–579.1) | 369.4 | (149.8–883.0) | 786.8 | (385.6–1520.6) | ||
| Direct non-medical costs§ | 26.6 | (2.2–133.2) | 104.8 | (33.8–268.4) | 206.9 | (89.1–443.7) | ||
| Transport | 5.9 | (0–22.2) | 25.2 | (12.1–59.2) | 39.9 | (18.2–91.4) | ||
| Food | 7.4 | (0–77.0) | 33.8 | (7.7–149.3) | 113.5 | (32.6–249.3) | ||
| Accommodation | 0 | (0–0) | 0 | (0–1.6) | 0.1 | (0–7.3) | ||
| Nutritional supplement | 0 | (0–14.8) | 5.7 | (0–29.5) | 17.2 | (0.5–48.8) | ||
| Indirect costs¶ | 0 | (0–29.6) | 2.8 | (0.1–64.2) | 12.7 | (0.2–194.3) | ||
| Total costs** | 230.1 | (38.5–849.5) | 551.0 | (223.5–1297.6) | 1185.5 | (596.0–2230.8) | ||